The deposition of proteins onto hydrogel substrates, including proteins found in the human tear film, has been reported previously. [1] [2] [3] [4] Human tears are composed of a wide variety of proteins, lipids, and mucins, many of which may be adsorbed by the contact lens surface. [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] These deposits can result in discomfort, 16 -18 reduced visual acuity, 19 and giant papillary conjunctivitis (GPC). 20 Lysozyme represents a significant proportion of the total protein found in tears and is the major protein deposited on Food and Drug Administration (FDA) group IV contact lenses. 6, 14, 15, [21] [22] [23] It was first shown by Karageozian 24 that lysozyme may be a significant contributor to the problems encountered by contact lens wearers, because lysozyme is selectively adsorbed and denatured on the surface of the contact lens. Other researchers 25, 26 have since reported similar findings.
A new class of highly oxygen-permeable hydrogel contact lens materials (silicone hydrogel) has recently become commercialized. These materials transmit significantly more oxygen to the cornea than conventional hydrogel lenses do 27 and represent a class of materials that are increasingly used for patients on an overnight and a daily-wear basis. 28 The authors' group 29 -31 and others 32 have shown that silicone hydrogel lens materials acquire considerably less lysozyme deposit than conventional contact lens materials do, particularly FDA group IV materials. To date, the authors' group is the only one to report the activity of the lysozyme deposited on these new materials, 29, 30, 33 by showing that the lysozyme deposited on the first-generation silicone hydrogel materials is largely denatured.
The activity of protein deposited on hydrogel contact lenses is of interest because several studies have suggested that GPC is related to protein deposition and denaturation on the contact lens surface. 34 -36 Silicone hydrogel lenses have shown an increased prevalence of GPC, as compared with conventional hydrogel lenses. [37] [38] [39] [40] One component that could be of etiologic significance is that the increased modulus of the silicone hydrogel lens materials 27 induces a mechanical GPC similar to that seen from the presence of loose corneal sutures. [37] [38] [39] [40] However, this type of GPC is frequently rapid in onset and is alleviated by refitting into lens materials that are lower in modulus. 40 Some patients develop GPC with silicone hydrogel lenses over a longer period, when modulus may be less influential, so a factor to be considered is the degree to which lysozyme is denatured on the lens surface.
To date, few studies have compared lysozyme deposition and activity on silicone hydrogel versus conventional hydrogel lens materials. 29, 30 There are several new silicone hydrogel materials that have been released for which no data are currently available. The purpose of this study was to determine the deposition and conformational state of lysozyme deposited on a wide variety of conventional and silicone hydrogel lens materials by using an in vitro model.
MATERIALS AND METHODS

Materials and Reagents
The physical characteristics and compositions of the lens materials used in this study are described in Table 1 .
All PhastSystem precast gels, buffer strips, well combs, filter paper, and ECL-Plus kits were purchased from Amersham Pharmacia Biotech (Baie d'Urfe, Canada). Immuno-Blot polyvinylidene difluoride (PVDF) membrane was purchased from Bio-Rad Laboratories (Mississauga, Canada). Polyclonal rabbit antihen egg lysozyme was purchased from Cedarlane Laboratories (Hornby, Canada), and goat antirabbit IgG-HRP and hen egg lysozyme (HEL) were purchased from Sigma (St.Louis, MO). A product developed for stabilizing proteins and enzymes (Bio-Stab Biomolecule Storage Solution [BIOSTAB]) 31 was also purchased from Sigma. All other reagents purchased were of appropriate analytical grade.
Preparation of Doping Solution and Lenses
The HEL doping solution was made by dissolving granular HEL in an appropriate volume of sterile phosphate-buffered solution (PBS), at a pH of 7.4. Lenses were doped in a 2 mg/mL of this HEL solution, whose concentration was verified by using a standard protein assay (BCA, Pierce, IL).
Lenses (six replicates) were doped for 17 days to mimic the typical clinical replacement schedule (2 weeks) used with many of the lenses examined in the study. Negative controls consisted of all lens types soaked in PBS alone.
Initially, each lens was removed from its packaging solution and rinsed in sterile PBS solution (10 mL) for 24 hours in polypropylene tubes (VWR International, Mississauga, Canada). Amber vials (VWR International) were used for the doping to ensure that no extraneous light resulted in alterations to lysozyme conformation. Each amber vial was then filled with 2 mL of the appropriate solution (i.e., HEL or PBS).
After 24 hours of rinsing, the lenses were transferred from the PBS to the doping solution. All samples were then placed in a shaking water bath, at 37°C.
Hen Egg Lysozyme Standards for Activity and Protein Assays
The activity HEL assay standards were processed under exactly the same conditions as the samples. HEL standards for protein assays were prepared gravimetrically.
Extraction of Proteins From Lenses
At the end of the 17 days, the lenses were removed from the vials, briefly rinsed in PBS, and then dabbed on Kimwipes (VWR International) to remove any excess PBS. The rinse removed any nonadsorbed HEL so that the quantification would not be affected by nonadsorbed proteins. Each of the lenses was then placed in a vial containing a suitable extraction solvent. ACUVUE 2 (etafilcon A), Proclear (omafilcon A), PureVision (balafilcon A), Focus NIGHT & DAY (lotrafilcon A), and O 2 Optix (lotrafilcon B; O2) were placed into a 50:50 mixture of 0.2% trifluoroacetic acid and acetonitrile, whereas ACUVUE Advance (galyfilcon A) and ACUVUE OASYS (senofilcon A) were placed into a 50:50 mixture of 0.02% trifluoroacetic acid and acetonitrile. Previous work in the authors' laboratory (unpublished) showed that a 50:50 mixture of 0.02% trifluoroacetic acid and acetonitrile is a more efficient method for extracting protein from ACUVUE OASYS and ACUVUE Advance lens materials. In addition, extraction of ACUVUE OASYS, Focus NIGHT & DAY, and O 2 Optix was undertaken with appropriate solvent systems, in the presence and absence of 200 g bovine serum albumin (BSA), because of the low mass of protein present.
All lenses were stored in darkness at room temperature for 24 hours during the extraction process. 21 Lenses were subsequently removed and discarded; extraction solutions were placed into sterile Eppendorf tubes and lyophilized to dryness by using the Savant Speed Vac (Halbrook, NY).
Determination of Lysozyme Activity
Lyophilized protein extracts were resuspended in tear dilution buffer (10 mM Tris [pH 8.0] and 1.0 mM EDTA). At this point, the percentage activity was assayed by using a micro Micrococcus lysodeikticus assay with HEL as the standard. The HEL standard was subjected to the same conditions as the lenses (17 days at 37°C). A standard curve was plotted by linear regression of initial lysozyme velocity against the absolute quantity of active HEL, and active mass was determined by extrapolation. 
Determination of Total Lysozyme
A Western blot (PhastSystem) was used to determine the total HEL (active and inactive) in each of the samples. Immunoreactivity was visualized with ECL Plus chemiluminescent substrate, as previously described. 29, 31 Figure 1 shows a typical gel and the subsequent standard curve obtained after the imaging. The total HEL was used along with the absolute amount of active HEL to determine the percentage activity for each of the lenses studied.
Data Analysis
Statistical analysis was undertaken by using Statistica 7 (Stat-Soft, Inc., Tulsa, OK). All data are reported as mean Ϯ standard deviation and were analyzed by using a one-way analysis of variance, with a post hoc Tukey test. Correlation coefficients were undertaken by using a Pearson product moment correlation. Statistical significance was taken at a level of PϽ0.05 in all cases. Figure 2 shows the total HEL adsorbed by each lens material. In terms of total HEL accumulation, ACUVUE 2 showed the most, with 1,800 g per lens, and Proclear and PureVision were the next highest, with 68 g and 44 g per lens, respectively. Focus NIGHT & DAY deposited the least, with 2 g per lens, and ACUVUE OASYS, O 2 Optix, and ACUVUE Advance lenses accumulated similar amounts of HEL, at 6 to 9 g per lens. The HEL deposited on ACUVUE 2 lenses was statistically different from all other lens materials (PϽ0.001). The FDA group II material (Proclear) acquired more HEL deposit than all the remaining lens materials (PϽ0.01 compared with PureVision and PϽ0.001 compared with the remaining silicone hydrogel materials). The FDA group III silicone hydrogel material (PureVision) was higher than all the other silicone hydrogel materials (PϽ0.001). Lotrafilcon A (Focus NIGHT & DAY) showed less HEL deposition than all other lens materials (PϽ0.01), and the remaining silicone hydrogels (ACUVUE Advance, ACUVUE OASYS, and O 2 Optix) were statistically similar (PϭNS).
RESULTS
In terms of activity, ACUVUE OASYS data came from the extraction procedure that included BSA, whereas the activity of O 2 Optix and Focus NIGHT & DAY did not, because activity was not improved with the addition of BSA. Figure 3 shows the percentage active protein for each lens material. HEL deposited on ACUVUE 2 showed the greatest activity (91% Ϯ 5%), whereas Focus NIGHT & DAY (24% Ϯ 5%) and O 2 Optix (23% Ϯ 11%) showed the lowest activity. Lysozyme deposited on other lens materials showed intermediate activity, with values of 60% Ϯ 15% for ACUVUE Advance, 51% Ϯ 9% for ACUVUE OASYS, 58% Ϯ 8% for PureVision, and 38% Ϯ 4% for Proclear. ACUVUE 2 activity was statistically different from all lens types (PϽ0.001). The quantities of active lysozyme found on Focus NIGHT & DAY and O 2 Optix were not statistically different from each other (PϭNS), but each was statistically lower than that for all other lens types (PϽ0.03). ACUVUE Advance, ACUVUE OASYS, and PureVision were not statistically different from each other (PϭNS). Proclear lenses showed lower activity than ACUVUE Advance and PureVision did (PϽ0.01), but they were not different from ACUVUE OASYS lenses (PϭNS). To determine whether any association existed between the water content of the materials, degree of HEL activity, and the activity of the protein deposited, a Pearson product moment correlation was performed. There was no correlation between the water content and HEL deposition (r ϭ 0.52, Pϭ0.23) or percentage activity (r ϭ 0.57, Pϭ0.12), but there was a significant correlation between the degree of HEL deposition and its activity (r ϭ 0.78, Pϭ0.04).
DISCUSSION
This study quantified the activity and amount of lysozyme deposited on commercially available silicone hydrogel lens materials, in comparison with two currently available poly (2-hydroxyethyl methacrylate) Ϫ (polyHEMAϪ) based hydrogel materials. The study used HEL rather than human lysozyme because of cost considerations. Previous work has shown that the secondary structures of human lysozyme and HEL are similar, [41] [42] [43] [44] and this fact coupled with similar data from other ex vivo studies in which lenses have been collected and analyzed for lysozyme activity and quantity after wear, 29 -31,33 provides a high level of confidence for the applicability of the data from this in vitro study to human clinical studies. Figure 2 clearly shows that etafilcon A acquired substantially more lysozyme deposit than all other lens materials (PϽ0.001), and lotrafilcon A acquired very low levels of lysozyme deposit, with the levels of HEL deposited being lower than all other lens materials (etafilcon A and omafilcon A, PϽ0.001 and other silicone hydrogels, PϽ0.01). The degree to which the deposited lysozyme is denatured (Fig. 3) has been the subject of few reports thus far, 29 -31,33 and these studies have reported on only etafilcon A, balafilcon A, and lotrafilcon A. The current study found levels of activity of the deposited lysozyme similar to those previously reported for these three materials. Figure 3 shows that the FDA group IV material (etafilcon A) retained the greatest amount of activity, at approximately 90%, and the two silicone hydrogel materials with the lowest water content (lotrafilcon A [Focus NIGHT & DAY] and lotrafilcon B [O 2 Optix]) showed the greatest loss in activity, with approximately only 25% of the deposited lysozyme being active. The other lens materials showed intermediate amounts of activity, with 40% to 60% of the deposited HEL being fully active.
To date, relatively few studies have reported protein deposition levels on silicone hydrogel materials, 29 -33,45 and the current in vitro data are similar to those reported in other ex vivo studies. When the total protein results are reviewed (Fig. 2) , it is clear that etafilcon A acquires levels of HEL deposits far greater than all other materials examined, which is similar to the findings of other previously published works. 6 -8,15,23,46 In contrast, lotrafilcon A acquired negligible amounts of HEL deposit, supporting previous ex vivo studies from the authors' group 30, 31, 33 and others 32 showing that lotrafilcon A (Focus NIGHT & DAY) acquires very low levels of lysozyme deposit. The other lens materials acquired levels of HEL deposit far less than etafilcon A, but significantly greater than lotrafilcon A. Of the remaining five materials, three of the silicone hydrogels (ACUVUE Advance, ACUVUE OASYS, and O 2 Optix) acquired similarly low levels of HEL deposit, with the remaining silicone hydrogel (PureVision) behaving similarly to the only FDA group II material examined (omafilcon A).
These differences in HEL deposition and activity can be largely explained in terms of the bulk and surface characteristics of the polymers under consideration. Etafilcon A is an FDA group IV hydrogel comprising polyHEMA in conjunction with methacrylic acid. The primary function of the methacrylic acid is to increase the water content of the hydrogel material greater than that of polyHEMA, at 38%. 47 However, its incorporation imparts an overall net negative charge to the polymer, 47 and the presence of this large number of negatively charged binding sites results in the attraction of high levels of positively charged proteins, such as lysozyme. In comparison, omafilcon A is a neutral, FDA group II hydrogel comprised of polyHEMA and the biocompatible monomer phosphorylcholine. 48 -51 Phosphorylcholine has been shown to be highly resistant to protein deposition in both hydrogel membranes 48, 52, 53 and when fabricated into contact lenses, 54, 55 and the data from this study further show that phosphorylcholine-based contact lens materials acquire relatively low levels of protein deposit.
Silicone hydrogel materials are complex polymers containing a variety of conventional hydrogel monomers and siloxane macromers (Table 1) . Oxygen transmissibility primarily depends on the siloxane phase, and thus, silicone hydrogel materials have lower water contents than conventional hydrogel materials do. The incorporation of silicone groups results in an increased degree of hydrophobicity at the surface of silicone hydrogel lenses, 56 -58 and a variety of strategies are used to enhance their wettability. The lotrafilcon A and lotrafilcon B materials are plasma-coated with a 25-nm thick, high-refractive index polymer composed of a mixture of trimethylsilane, oxygen, and methane. 27,59 -64 The balafilcon A material is plasma-oxidized in a manner that changes the silicone on the surface into a highly wettable silicate surface. 27,64 -66 The galyfilcon A and senofilcon A materials incorporate an internal wetting agent based on polyvinyl pyrrolidone, which coats the entire lens surface and enhances wettability. 45, 64, 67, 68 In comparison with the conventional polyHEMA-based materials, most of the silicone hydrogel materials acquired much lower levels of HEL deposit, with the exception of balafilcon A (Pure-Vision), which behaved similarly to omafilcon A. The low levels of HEL deposition are the result of the low water content, lack of ionic binding sites, and surface treatments, all of which contribute to the resistance to deposition seen in this study. The higher levels for balafilcon A are caused by the combination of the relatively incomplete nature of the surface treatment, 64 the porous internal structure of the balafilcon polymer, 64, 69, 70 and the fact that it remains the only silicone hydrogel material with a sufficient degree of ionic sites that it is classified as an FDA group III material (low water content and ionic material). The lotrafilcon materials are neutral in charge (i.e., FDA group I materials) and have a complete 25-nm thick surface plasma coating, 27,59 -64 which acts to lock out access to the underlying polymer and minimize protein deposition. However, despite these differences, it must be appreciated that the degree of deposition on the balafilcon A material is still remarkably low.
The protein activity data also show interesting differences between the lens materials, with ACUVUE 2 showing the greatest activity and the two lotrafilcon materials showing the lowest activity, with the other silicone hydrogel materials showing intermediate activities. Protein denaturation is a complex process and is influenced by a number of variables, including contact time with the substrate, chemical composition of the substrate, surrounding pH, the type of protein, and temperature. Several studies also suggest that when proteins are exposed to strongly hydrophobic surfaces, they are more likely to denature. 4, 23, [71] [72] [73] [74] It is noteworthy that there was a positive correlation between the degree of deposition and activity of the protein deposited (r ϭ 0.78, Pϭ0.04). This begs the question of whether the protein deposited on the lens material actually helps to prevent subsequent denaturation; this area requires further experimentation. This study investigated the denaturation of lysozyme when the lenses were incubated in a solution containing only one type of protein, namely lysozyme. Another important factor to consider relates to the effect of other substances in the tear film (e.g., proteins other than lysozyme, lipids, and mucins) on subsequent denaturation of lysozyme deposited on lens materials. Hence, in future studies, it would be interesting to use a more complex protein solution and investigate the denaturation of deposited lysozyme when in combination with other tear film components.
In conclusion, this study has shown that silicone hydrogel materials acquire less lysozyme deposit than conventional FDA group II (Proclear) or group IV (ACUVUE 2) materials and that the level of lysozyme denaturation varies with the composition of the hydrogel material in question. These differences have potentially important clinical considerations for patients who may develop GPC when wearing silicone hydrogel lenses.
